Skip Ribbon Commands
Skip to main content

Key Milestones

2019
  • NCCS and Singapore Cancer Society sign a partnership agreement to provide holistic and seamless cancer support and intensify upstream prevention methods to reduce cancer incidence through a dedicated Cancer Genetics Service Screening Programme.
  • The first component of the proton therapy gantry arrives for installation at the site of the new building.


2018
  • The NCCS Oncology @ SKH is launched to bring cancer treatment closer to patients living in the north-eastern sector of Singapore.


2017
  • Founding Director, Prof Soo Khee Chee retires as Director of NCCS on 26 November 2017 and hands over the reins to Prof William Hwang Ying Khee, who is appointed Medical Director of NCCS.
  • Leads first-in-the-world liver cancer clinical trial to pioneer a treatment strategy that combines an immunotherapy drug with radioembolisation.
  • Ground-breaking ceremony for the New NCCS Building. The new comprehensive proton therapy facility, named the Goh Cheng Liang Proton Therapy Centre, will be located in the basement level of the new NCCS building.


2016
  • ​Hitachi Asia Ltd is awarded to provide the Proton Beam Therapy System for the Goh Cheng Liang Proton Therapy Centre.


2015
  • ​Collaborates with ASLAN Pharmaceuticals to research and develop therapies for Asia-Prevalent Tumour Types.
  • Wins Service Excellence Medallion Award - the first healthcare institution in Singapore to receive this award.
  • Launches Singapore’s first cancer education bus with Ain Society, to create cancer awareness in the community.


2014
  • ​Collaborates with Clearbridge BioMedics, together with the Pathology Department of the Singapore General Hospital, to set up region’s first Circulating Tumour Cell Centre of Research Excellence (CTC CoRE).
  • Signs Goyang Declaration in Seoul to push for a Tobacco-Free Generation (TFG) in Asia.
  • Receives $50 million donation from the Goh Foundation to set up the new Proton Beam Treatment Centre and for proton-related cancer treatment and research.
​2013
  • ​Launches NCCS Oncology Clinic @ CGH to bring cancer treatment closer to patients living in eastern Singapore.
  • Sets up the Integrated Translational Oncology Network together with Bayer Heathcare, Cancer Science Institute of Singapore, Duke-NUS Medical School, National University Cancer Institute, Singapore, Singapore General Hospital, A*STAR’s Singapore Bioimaging Consortium.
​2012
  • ​Partners BNP Paribas to launch the first NCCS Surgical Oncology Conference.
  • Announces plans to offer Proton Therapy to patients in 2020/2021.
  • Introduces Intraoperative Radiotherapy (IORT) for breast cancer patients.
​2011
  • Opens Centre for Peritoneal and Pelvic Cancers.
  • Partners Wellcome Trust Sanger Institute (UK) and Van Andel Research Institute (USA), leading to the discovery of a new gene that is mutated in one out of three cancer patients with renal cancers.
  • Department of Medical Oncology introduces a comprehensive geriatric assessment for elderly patients with colorectal, lung and genitourinary cancers to assess their suitability for treatment.
  • Department of Surgical Oncology introduces the Breast Cancer Survivorship Programme, which enables survivors to receive comprehensive disease surveillance assistance from Advanced Practitioner Nurses.
​2010
  • ​Embarks on its Service Quality Excellence Programme.
  • Receives accreditation from the Joint Commission International (JCI). It is the only national cancer centre in the region to be recognised for healthcare standards, patient safety and clinical governance.
  • Supports the proposal to deny the sale of tobacco products to citizens born in or after the year 2000. The proposal is presented at the SingHealth Duke-NUS Scientific Congress
​2009
  • Launches the BNP Paribas-NCCS Regional Fellowship Programme. The first programme is conferred to a physician from Vietnam.
2008
  • ​Introduces Image Guided Radiotherapy (IGRT), a new technique that enhances cancer control with fewer side effects.
  • Partners Four Seasons Hotel Singapore and The Regent Singapore for the inaugural launch of the annual Run For Hope to raise funds for cancer research.
  • Minister for Health Mr Khaw Boon Wan opens Lien Centre for Palliative Care.
2007
  • ​Establishes Geriatric Oncology Programme.
  • Signs an international collaboration agreement formalising an alliance to customise Asian patients’ cancer drug response, with the Van Andel Research Institute (VARI) based in Michigan, USA.
  • Establishes Humphrey Oei Institute of Cancer Research (HOICR). The institute comprises the three founding research divisions: Cellular and Molecular Research, Medical Sciences, and Clinical Trials and Epidemiological Sciences.
​2006
  • ​Acquires a 64-slice Multi-Detector Computed Tomography (MDCT) to enable early detection and treatment of cancer.
  • Signs an MOU with Rajiv Gandhi Centre for Biotechnology and Regional Cancer Centre in Thiruvananthapuram, India to conduct biomedical research and study head and neck cancers.
  • Leads Singapore’s first bench-to-bedside Dendritic Cell Vaccine trial that produces encouraging results for advanced colon cancer patients.
  • Establishes the Health Professionals and Undergraduates (HPU) Education Unit to provide training opportunities for medical students to learn from veteran medical staff and clinicians.
​2005
  • ​Signs a landmark agreement with eight Asian National Cancer Centres to collectively embark on cancer prevention advocacy, cancer research, training, as well as collaboration, with the World Health Organisation (WHO) and International Agency for Research on Cancer (IARC).
  • Becomes the secretariat for the Asian National Cancer Centers Alliance (ANCCA).
  • Partners Children’s Cancer Foundation and KK Women’s and Children’s Hospital for research on rhabdomyosarcoma, a fast growing malignant tumour that affects children.
​2004
  • ​Pioneers a new technique, Photodynamic Diagnosis and Treatment (PDT) that uses fluorescence diagnosis and drug-induced light therapy to diagnose and treat cancer.
​2003
  • ​Plays a key role in the national crisis management of SARS.
2002
  • ​Division of Radiation Oncology introduces Singapore’s first Intensity Modulated Radiotherapy (IMRT) treatment to improve tumour coverage and decrease side effects of treatment.
​2001
  • ​Establishes Department of Psychosocial Oncology.
​2000
  • ​Official opening of NCCS by Mr Lim Hng Kiang, Minister for Health.
  • Commences operations with two clinical divisions, Medical Oncology and Radiation Oncology, and three research divisions. Divisions of Surgical Oncology, Palliative Medicine and Oncologic Imaging are also established within the year.
  • Becomes part of Singapore Health Services (SingHealth), one of two public healthcare clusters.
  • Establishes Mammography Suite.
​1999
  • ​Official launch of Cancer Helpline by Mr Chan Soo Sen, Parliamentary Secretary (Prime Minister’s Office and Ministry of Health).
​1997
  • ​Obtains its status of National Specialist Centre and becomes a fully autonomous institution. Appoints Professor Soo Khee Chee as Director of NCCS.
​1996
  • ​Minister for Health, BG (NS) George Yeo launches new premise for Singapore Cancer Centre at SGH Campus.
1993
  • ​Commences as a specialised Strategic Business Unit within the Singapore General Hospital (SGH).
​1992
  • ​The Government reviews National Health Policies and recommends the establishment of a national cancer centre in Singapore.
1991
  • ​A White Paper was introduced in Parliament to set up a national cancer centre in Singapore.